Coinfection of COVID-19 and Tuberculosis in Uganda
| dc.contributor.author | Nuwagira, Edwin | |
| dc.contributor.author | Mpagama, Stellah G | |
| dc.contributor.author | Katusiime, Asumpta | |
| dc.contributor.author | Natamba, Bobson | |
| dc.contributor.author | Baluku, Joseph Baruch | |
| dc.contributor.author | Lai, Peggy S | |
| dc.date.accessioned | 2024-09-20T11:32:10Z | |
| dc.date.available | 2024-09-20T11:32:10Z | |
| dc.date.issued | 2023-06 | |
| dc.description.abstract | The clinical features and outcomes of tuberculosis (TB) and COVID-19 coinfection are not well established. This short report describes 11 people with TB/COVID-19 coinfection in Uganda. The mean age was 46.9 ± 14.5 years; eight (72.7%) were male and two (18.2%) were coinfected with HIV. All patients presented with cough whose median duration was 71.1 (interquartile range, 33.1, 109) days. Eight (72.7%) had mild COVID-19 whereas two (18.2%) died, including one with advanced HIV disease. All patients were treated with first-line anti-TB drugs and adjunct therapy for COVID-19 using national treatment guidelines. This report presents the possibility of the coexistence of the two diseases and calls for more vigilance, screening, and collective prevention measures for both COVID-19 and TB. MEDLINE | |
| dc.identifier.citation | Nuwagira, Edwin, Stellah G. Mpagama, Asumpta Katusiime, et al. 'Coinfection of COVID-19 and Tuberculosis in Uganda', The American Journal of Tropical Medicine and Hygiene, vol. 108/no. 6, (2023), pp. 1240-1243. | |
| dc.identifier.issn | ISSN 0002-9637 | |
| dc.identifier.issn | EISSN 1476-1645 | |
| dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/9625 | |
| dc.language.iso | en | |
| dc.publisher | Institute of Tropical Medicine | |
| dc.title | Coinfection of COVID-19 and Tuberculosis in Uganda | |
| dc.type | Article |